Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer
Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer have?
Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer has 25 citations in the OpenAlex counts ScholarIQ stores.
When was Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer published?
Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer has 2023 year in the ScholarIQ index.
What is the open-access status of Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer?
Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer has gold oa status in the ScholarIQ index.
What is the DOI of Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer?
The DOI for Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer is on the source record.
What is the PMID of Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer?
The PMID for Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer is on the source record.
What is the OpenAlex record for Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer?
The OpenAlex for Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer is on the source record.